ARTIVION, INC.

Artivion manufactures and distributes medical devices and implantable human tissues for cardiac, vascular, and thoracic surgical procedures. The company's product portfolio includes BioGlue, a surgical adhesive for use in cardiac and vascular applications; PhotoFix bovine pericardial patches; and aortic arch stent grafts marketed under brand names including E-vita Open and NEXUS. Additional offerings encompass synthetic vascular grafts, hemostatic agents, prosthetic heart valves under the On-X label, and vascular preservation services for harvested tissues.

The company operates across multiple product categories serving distinct surgical specialties. Its stent graft portfolio addresses infrarenal abdominal, thoracoabdominal, and peripheral aortic disease treatment. The cardiac devices segment includes prosthetic valves and sutures for cardiac reconstruction. Artivion also provides specialized services including cryopreservation of vascular tissue and pyrolytic coating applications for third-party medical device manufacturers.

Artivion operates internationally with distribution channels reaching cardiac surgeons, vascular surgeons, and hospital systems worldwide. The company was incorporated in Delaware in 1984 and is headquartered in Kennesaw, Georgia. It maintains manufacturing and processing facilities to support its product lines and preservation services business.